Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Macitentan n-butyl analogue, a derivative of Macitentan, functions as an orally active dual antagonist targeting both endothelin ETA and ETB receptors. This compound shows promise for treating idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), leveraging its non-peptide structure for potential therapeutic applications.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | $ 996.00 |
Description | Macitentan n-butyl analogue, a derivative of Macitentan, functions as an orally active dual antagonist targeting both endothelin ETA and ETB receptors. This compound shows promise for treating idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), leveraging its non-peptide structure for potential therapeutic applications. |
Molecular Weight | 587.29 |
Formula | C20H21Br2N5O4S |
CAS No. | 556797-16-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Macitentan (n-butyl analogue) 556797-16-1 Others Macitentan Macitentan (nbutyl analogue) Macitentan (n butyl analogue) n-butyl analogue inhibitor inhibit